We recently compiled a list of the 12 Best Performing Healthcare Stocks to Buy Right Now. ABIVAX Société Anonyme is one of them. ABIVAX Société Anonyme (NASDAQ:ABVX) is a clinical-stage biotechnology company developing therapies to regulate immune responses in chronic inflammatory diseases. Its lead candidate, obefazimod (ABX464), is an oral miR-124 enhancer currently in Phase 3 trials for ulcerative colitis (UC) and Phase 2b trials for Crohn’s disease. In September 2025, ABVX announced it would present ...